Best Practices in Medical Affairs Management & Liaison to Maximise Value Over the Product Lifecycle is a conference that covers topics such as:
Ways to engage and map with KOLs and other payers, prescribers, pharmacies, patient groups and stakeholders
Medical affairs in new pharmaceutical industry commercial models
How crucial are medical liaisons to the communication of safety, effectiveness and cost-effectiveness in support of commercial teams
Best practices in late-phase research, including patient registries, observational studies and investigator initiated studies
Best Practices in Medical Affairs Management & Liaison to Maximise Value Over the Product Lifecycle brings together executives and managers from Pharma companies with responsibilities in Medical Science Liaisons, edical Affairs, Health Outcomes, Medical Education, Medical Marketing, & Economics, Product management, Lifecycle management, Late Phase Clinical development, KOL & stakeholder engagement, Medical Advisor, Field Sales and Scientific Affairs.